Bristol-Myers Squibb
BMY
#191
Rank
NZ$208.17 B
Marketcap
NZ$101.94
Share price
3.85%
Change (1 day)
35.30%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): NZ$6.10

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$6.31. In 2025 the company made an earnings per share (EPS) of NZ$6.13 an increase over its 2024 EPS that were of NZ-$7.83.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.10-0.45%
2025NZ$6.13-178.28%
2024NZ-$7.83-213.92%
2023NZ$6.8830.2%
2022NZ$5.28-6.04%
2021NZ$5.62-179.29%
2020NZ-$7.09-281.37%
2019NZ$3.91-27.21%
2018NZ$5.37
2016NZ$4.73175.26%
2015NZ$1.72-19.83%
2014NZ$2.14-22.44%
2013NZ$2.7634.48%
2012NZ$2.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.48 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.44 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.64-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$50.02 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.66 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.54-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$16.57 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.30-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.32 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK